William F. Glass

2.5k total citations
63 papers, 2.0k citations indexed

About

William F. Glass is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Nephrology. According to data from OpenAlex, William F. Glass has authored 63 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 17 papers in Pulmonary and Respiratory Medicine and 16 papers in Nephrology. Recurrent topics in William F. Glass's work include Renal Diseases and Glomerulopathies (15 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Cell Adhesion Molecules Research (10 papers). William F. Glass is often cited by papers focused on Renal Diseases and Glomerulopathies (15 papers), Cancer Immunotherapy and Biomarkers (10 papers) and Cell Adhesion Molecules Research (10 papers). William F. Glass collaborates with scholars based in United States, Egypt and Canada. William F. Glass's co-authors include Robert C. Briggs, Lubomir S. Hnilica, Jeffrey I. Kreisberg, Robert A. Radnik, Suzanne H. Ayo, Jeffrey L. Barnes, Jean Wu, Ya‐Huan Lou, Dean R. Appling and John Hicks and has published in prestigious journals such as Science, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

William F. Glass

57 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William F. Glass United States 23 768 418 386 383 322 63 2.0k
David A. Alcorta United States 25 1.4k 1.9× 81 0.2× 594 1.5× 417 1.1× 492 1.5× 38 2.6k
Susan W. Sunnarborg United States 18 1.4k 1.8× 145 0.3× 1.1k 2.9× 500 1.3× 218 0.7× 23 3.1k
Béatrice Charreau France 30 809 1.1× 96 0.2× 287 0.7× 1.1k 3.0× 121 0.4× 98 2.7k
Gloria A. Preston United States 24 676 0.9× 276 0.7× 140 0.4× 818 2.1× 1.2k 3.6× 39 2.2k
Yannick Jacques France 34 1.0k 1.3× 274 0.7× 1.4k 3.5× 2.7k 7.1× 132 0.4× 93 4.2k
Kuang‐Hui Sun Taiwan 30 948 1.2× 102 0.2× 444 1.2× 946 2.5× 182 0.6× 83 2.2k
Alexander Faerman Israel 23 2.0k 2.5× 90 0.2× 319 0.8× 194 0.5× 142 0.4× 41 2.8k
Manousos Makridakis Greece 27 1.0k 1.3× 92 0.2× 196 0.5× 213 0.6× 223 0.7× 86 2.0k
Hui‐Ming Chang United States 21 1.0k 1.3× 111 0.3× 362 0.9× 531 1.4× 138 0.4× 49 2.1k
Chizu Tanikawa Japan 28 1.9k 2.5× 121 0.3× 1.2k 3.0× 377 1.0× 436 1.4× 57 3.1k

Countries citing papers authored by William F. Glass

Since Specialization
Citations

This map shows the geographic impact of William F. Glass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William F. Glass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William F. Glass more than expected).

Fields of papers citing papers by William F. Glass

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William F. Glass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William F. Glass. The network helps show where William F. Glass may publish in the future.

Co-authorship network of co-authors of William F. Glass

This figure shows the co-authorship network connecting the top 25 collaborators of William F. Glass. A scholar is included among the top collaborators of William F. Glass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William F. Glass. William F. Glass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Msaouel, Pavlos, et al.. (2021). Treatment of PLA2R-Negative Membranous Nephropathy in the Setting of Immune Checkpoint Inhibitor and Renal Cell Carcinoma. Journal of the American Society of Nephrology. 32(10S). 575–575.
3.
Wu, Jean, Colin Carlock, Junbo Shim, et al.. (2021). Requirement of brain interleukin33 for aquaporin4 expression in astrocytes and glymphatic drainage of abnormal tau. Molecular Psychiatry. 26(10). 5912–5924. 37 indexed citations
4.
Lin, Jamie S., Nicolas L. Palaskas, Omar Mamlouk, et al.. (2020). Immune Checkpoint Inhibitor-Induced Renal and Cardiac Sarcoidosis. Journal of the American Society of Nephrology. 31(10S). 849–849.
5.
Mamlouk, Omar, Jamie S. Lin, Maen Abdelrahim, et al.. (2020). Checkpoint Inhibitor-Related Renal Vasculitis and Use of Rituximab. Journal of the American Society of Nephrology. 31(10S). 662–662. 2 indexed citations
6.
Richard‐Carpentier, Guillaume, et al.. (2020). Unique case of ANCA-negative pauci-immune necrotizing glomerulonephritis with diffuse alveolar hemorrhage, potentially associated with midostaurin. CEN Case Reports. 9(2). 147–151. 3 indexed citations
7.
Mamlouk, Omar, Umut Selamet, Maen Abdelrahim, et al.. (2019). Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience. Journal for ImmunoTherapy of Cancer. 7(1). 2–2. 199 indexed citations
8.
9.
10.
Barnes, Jeffrey L. & William F. Glass. (2011). Renal Interstitial Fibrosis: A Critical Evaluation of the Origin of Myofibroblasts. Contributions to nephrology. 169. 73–93. 79 indexed citations
11.
Glass, William F., et al.. (2011). Nephrotic Syndrome and UnrecognizedPlasmodium malariaeInfection in a US Navy Sailor 14 Years After Departing Nigeria. Journal of Travel Medicine. 18(4). 288–291. 22 indexed citations
12.
Southam, David S., Russ Ellis, Jennifer Wattie, William F. Glass, & Mark D. Inman. (2008). Goblet Cell Rebound and Airway Dysfunction with Corticosteroid Withdrawal in a Mouse Model of Asthma. American Journal of Respiratory and Critical Care Medicine. 178(11). 1115–1122. 22 indexed citations
13.
Harding, Pamela, et al.. (2003). COX-2 inhibition potentiates the antiproteinuric effect of enalapril in uninephrectomized SHR. Prostaglandins Leukotrienes and Essential Fatty Acids. 68(1). 17–25. 8 indexed citations
14.
Somers, Kenneth D., Daniel A. Holterman, Nazita Yousefieh, et al.. (2003). Orthotopic treatment model of prostate cancer and metastasis in the immunocompetent mouse: Efficacy of flt3 ligand immunotherapy. International Journal of Cancer. 107(5). 773–780. 29 indexed citations
15.
Wu, Jean, et al.. (2002). CD4+ T cells specific to a glomerular basement membrane antigen mediate glomerulonephritis. Journal of Clinical Investigation. 109(4). 517–524. 3 indexed citations
16.
Wu, Jean, John Hicks, Jason Borillo, William F. Glass, & Ya‐Huan Lou. (2002). CD4+ T cells specific to a glomerular basement membrane antigen mediate glomerulonephritis. Journal of Clinical Investigation. 109(4). 517–524. 113 indexed citations
17.
Schneider, Bernard F., et al.. (1995). Membranous glomerulonephritis associated with testicular seminoma. Journal of Internal Medicine. 237(6). 599–602. 5 indexed citations
18.
Glass, William F., Dean A. Troyer, & Jeffrey I. Kreisberg. (1994). Regulation of Mesangial Cell Function by Thrombin. Seminars in Thrombosis and Hemostasis. 20(4). 333–338. 3 indexed citations
19.
Glass, William F., et al.. (1988). Urokinase-dependent adhesion loss and shape change after cyclic adenosine monophosphate elevation in cultured rat mesangial cells.. Journal of Clinical Investigation. 82(6). 1992–2000. 30 indexed citations
20.
Briggs, John A. G., William F. Glass, R C Briggs, & L.S. Hnilica. (1983). The specificity of antibodies to chicken erythroid chromatin.. PubMed. 29(2). 189–98. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David A. Alcorta Breakdown of academic impact, for papers by Susan W. Sunnarborg Breakdown of academic impact, for papers by Béatrice Charreau Breakdown of academic impact, for papers by Gloria A. Preston Breakdown of academic impact, for papers by Yannick Jacques Breakdown of academic impact, for papers by Kuang‐Hui Sun Breakdown of academic impact, for papers by Alexander Faerman Breakdown of academic impact, for papers by Manousos Makridakis Breakdown of academic impact, for papers by Hui‐Ming Chang Breakdown of academic impact, for papers by Chizu Tanikawa
Rankless by CCL
2026